Study Objectives To evaluate if semaglutide 2.4 mg subcutaneously once weekly is superior to placebo when added to standard of care for preventing major adverse cardiovascular events in patients with established CVD and overweight or obesity but without diabetes
In a new spot from telehealth-provider Ro, the tennis great gives viewers granular detail about the effects of GLP-1 on her weight, joint stress, blood sugar and even cholesterol Im moving better on Ro, she tells viewers
Ketone bodies and ketogenic diets may exert neuroprotective effects by enhancing anti-apoptotic and antioxidant defences (e.g., via inhibition of mPTP opening, mitochondrial ROS production, and caspase activation, and activation of SIRT1/2/3PGC1FOXO1/3a and ERK/CREB/eNOS pathways, with Nrf2 engagement), and by modulating NAD-dependent signalling and epigenetic/post-translational regulation (including HDAC/p300-mediated histone modifications) that can upregulate neurotrophic programs such as BDNF expression [69]
No reconstitution required
But we have a fundamental challenge